Veradigm | MDRX - Eigenkapital Und Reserven

Aktienkurs
4.46
Täglich Wechseln
-0.29 -6.11%
Monatlich
4.21%
Jährlich
3.72%
Q2 Prognose
4.37




Eigenkapital Und Reserven Veränderung Datum
Alcidion AUD 89.64M 1.84M 2025-12
Ambu A/S DKK 6.04B 1000K 2025-12
Amplifon EUR 998.52M 28.44M 2025-12
Cardinal Health USD -2.83B 52M 2026-03
Centene USD 21.43B 1.47B 2026-03
Charles River Laboratories USD 2.9B 265.94M 2026-03
Cigna USD 42.21B 497M 2026-03
Coloplast 13.8B 2.32B 2025-12
Computer Programs Systems USD 165.74M 14.62M 2025-12
Convatec Group USD 1.69B 34M 2024-12
CVS Health USD 77.46B 2.24B 2026-03
Diasorin EUR 1.53B 151.64M 2025-06
Elevance Health USD 43.9B 124M 2026-03
General Electric Aerospace USD 18.06B 841M 2026-03
Gulf Medical Proj AED 1.22B 56.38M 2025-12
Humana USD 18.58B 923M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Laboratory Of America USD 8.73B 108.8M 2026-03
Maximus USD 1.7B 22.85M 2026-03
McKesson USD -2.17B 874M 2026-03
Med Life RON 483.77M 18.26M 2025-12
Molina Healthcare USD 4.08B 11M 2026-03
Omnicell USD 1.26B 24.82M 2026-03
Oriola-kd EUR 100.8M 17.1M 2025-12
Owens Minor USD -460.98M 31.47M 2025-12
Quest Diagnostics USD 7.37B 196M 2026-03
Rede D'or Sao Luiz BRL 19.35B 9.45B 2025-12
Siemens Healthineers EUR 18.21B 217M 2026-03
Sonova Holding CHF 2.66B 374.5M 2025-06
Supermax Corporation Bhd MYR 3.81B 124.21M 2025-12
UnitedHealth USD 101.7B 4.12B 2025-12
Veeva Systems USD 7.21B 174.12M 2025-12
Veradigm USD 1.02B 159.52M 2022-12
Xerox USD 299M 145M 2026-03